{"id":"desoxymycin","rwe":[],"tags":[{"label":"desoxymycin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"mervastrept","offLabel":[],"synonyms":["deoxydihydrostreptomycin","desoxymycin","dihydrodeoxystreptomycin","dihydrodesoxystreptomycin","mervastrept"],"timeline":[],"approvals":[],"brandName":"Mervastrept","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"desoxymycin","explanation":"Imagine your body's cells are like factories that make proteins to keep you healthy. Bacteria are like tiny factories that make proteins to harm you. Mervastrept stops these bacterial factories from making proteins by binding to a specific part of the factory, preventing them from producing the proteins they need to grow and multiply.","oneSentence":"Mervastrept works by inhibiting bacterial protein synthesis.","technicalDetail":"Mervastrept exerts its antibacterial effects by binding to the 30S subunit of the bacterial ribosome, thereby inhibiting the initiation of protein synthesis and ultimately leading to bacterial cell death."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3133","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=desoxymycin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:35:47.407143","biosimilars":[],"competitors":[],"genericName":"desoxymycin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"6B6534650A","CHEBI":"CHEBI:135831","UMLSCUI":"C0604952","PUBCHEM_CID":"11953824","MESH_SUPPLEMENTAL_RECORD_UI":"C011771"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Mervastrept (desoxymycin) is a small molecule drug of the desoxymycin class, but specific details about its development, commercial status, and approved indications are not available. As a desoxymycin, it is likely to target bacterial infections, but the exact target is unknown. The drug's pharmacokinetic properties, such as half-life and bioavailability, are also not disclosed. Mervastrept's commercial status, including patent status and generic availability, is unclear. Further research is needed to understand its clinical use and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}